Trial intelligence / Profile preview

Ginkgo biloba extract EGb 761 for prevention of noise-induced temporary hearing impairment

DRKS00006173Phase 2Completed

Sponsor
Schwabe Group
Start
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in noise-induced hearing loss (NIHL) comparing EGb 761 with Placebo (2 arms). Started Jun 2014; status: completed.

02

Drugs

ginkgo biloba extract
03

Conditions

noise-induced hearing loss (NIHL)

Beyond the preview

Go deeper on DRKS00006173.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00006173.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call